From: Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
Biomarker | YI’s derived cut-offs | OPA’s derived cut-offs | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
AUC | CL cut-off | YIa | OPA | PPA | NPA | CL cut-off | YI | OPAa | PPA | NPA | |
Aβ42 | 0.874 [0.840–0.903] | 12.1 | 0.659 [0.594–0.721] | 0.831 [0.798–0.861] | 0.852 [0.809–0.892] | 0.806 [0.753–0.851] | 11.6 | 0.659 [0.593–0.720] | 0.831 [0.798–0.861] | 0.855 [0.812–0.895] | 0.804 [0.750–0.849] |
pTau/Aβ42 | 0.974 [0.956–0.9985] | 28.8 | 0.886 [0.842–0.922] | 0.943 [0.921–0.961] | 0.941 [0.904–0.964] | 0.945 [0.915–0.970] | 28.8 | 0.886 [0.842–0.922] | 0.943 [0.921–0.961] | 0.941 [0.904–0.964] | 0.945 [0.915–0.970] |
tTau/Aβ42 | 0.961 [0.940–0.975] | 29.7 | 0.863 [0.818–0.905] | 0.931 [0.908–0.952] | 0.948 [0.912–0.970] | 0.915 [0.882–0.946] | 30.1 | 0.863 [0.818–0.905] | 0.931 [0.908–0.952] | 0.948 [0.911–0.970] | 0.915 [0.882–0.947] |
pTau | 0.833 [0.793–0.869] | 29.3 | 0.689 [0.629–0.745] | 0.822 [0.787–0.853] | 0.755 [0.704–0.798] | 0.934 [0.898–0.966] | 18.7 | 0.680 [0.610–0.732] | 0.823 [0.787–0.852] | 0.773 [0.726–0.816] | 0.907 [0.856–0.939] |
tTau | 0.774 [0.727–0.814] | 28.6 | 0.573 [0.505–0.640] | 0.781 [0.747–0.815] | 0.745 [0.693–0.792] | 0.828 [0.779–0.875] | 26.7 | 0.573 [0.502–0.639] | 0.781 [0.745–0.815] | 0.748 [0.697–0.795] | 0.825 [0.773–0.870] |